General Announcement::Outcome of the Board Meeting June 26, 2020

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
27-Jun-2020 00:03:11
Status
New
Announcement Sub Title
Outcome of the Board Meeting June 26, 2020
Announcement Reference
SG200627OTHR6HA6
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
26/06/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on June 26, 2020, which commenced at 05.00 p.m. and concluded at 8.40 p.m., considered and approved the following:

1.Audited Financial Results for the year ended March 31, 2020. Pursuant to regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, find enclosed herewith the said results together with Management Discussion & Analysis, Press Release, Auditors Report and Declaration of unmodified opinion. These are also being made available on the website of the Company at www.glenmarkpharma.com

Attachments

SGX_RESULT_26062020.pdf
Total size =5851K